Carolyn M. Felzer
Profile
Carolyn M.
Felzer worked as an Interim Finance Director at Arena Pharmaceuticals, Inc. from 2006 to 2011 and as a Controller at Dendreon Corp.
Former positions of Carolyn M. Felzer
| Companies | Position | End |
|---|---|---|
| ARENA PHARMACEUTICALS | Director of Finance/CFO | 22/11/2011 |
| DENDREON CORPORATION | Comptroller/Controller/Auditor | - |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
- Stock Market
- Insiders
- Carolyn M. Felzer
